LNSR
LENSAR Inc
NASDAQ: LNSR · HEALTHCARE · MEDICAL DEVICES
$5.23
-2.97% today
Updated 2026-04-30
Market cap
$63.02M
P/E ratio
—
P/S ratio
1.08x
EPS (TTM)
$-2.87
Dividend yield
—
52W range
$5 – $14
Volume
0.1M
LENSAR Inc (LNSR) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-1.89M | $-12.59M | $-13.79M | $-8.97M | $-14.86M | $-9.66M | $-2.27M | $-14.83M |
| Capital expenditures | $3.25M | $2.09M | $366000.00 | $354000.00 | $115000.00 | $236000.00 | $156000.00 | $83000.00 |
| Depreciation | — | — | — | — | — | — | — | — |
| Stock-based comp | $1.32M | $102000.00 | $9.04M | $6.87M | $6.61M | $5.54M | $2.67M | $3.14M |
| Free cash flow | $-5.13M | $-14.68M | $-14.16M | $-9.32M | $-14.97M | $-9.89M | $-2.43M | $-14.91M |
| Investing cash flow | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — |
| Dividends paid | $198000.00 | $31000.00 | $1.86M | $0.00 | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — |